These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 24095750)

  • 1. 2-(2-Hydrazinyl)thiazole derivatives: design, synthesis and in vitro antimycobacterial studies.
    Makam P; Kankanala R; Prakash A; Kannan T
    Eur J Med Chem; 2013 Nov; 69():564-76. PubMed ID: 24095750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antimycobacterial activities of some new thiazolylhydrazone derivatives.
    Ozadali K; Tan OU; Yogeeswari P; Dharmarajan S; Balkan A
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1695-7. PubMed ID: 24631185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in silico antimalarial activity of 2-(2-hydrazinyl)thiazole derivatives.
    Makam P; Thakur PK; Kannan T
    Eur J Pharm Sci; 2014 Feb; 52():138-45. PubMed ID: 24231338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of 5-nitrothiazole derivatives: identification of leads against both replicative and latent Mycobacterium tuberculosis.
    Jeankumar VU; Chandran M; Samala G; Alvala M; Koushik PV; Yogeeswari P; Salina EG; Sriram D
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7414-7. PubMed ID: 23137434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Aminothiazole derivatives as antimycobacterial agents: Synthesis, characterization, in vitro and in silico studies.
    Makam P; Kannan T
    Eur J Med Chem; 2014 Nov; 87():643-56. PubMed ID: 25305331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G; Devi PB; Saxena S; Meda N; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2016 Mar; 24(6):1298-307. PubMed ID: 26867485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of substituted 4-arylthiazol-2-amino derivatives as potent growth inhibitors of replicating Mycobacterium tuberculosis H₃₇Rv.
    Roy KK; Singh S; Sharma SK; Srivastava R; Chaturvedi V; Saxena AK
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5589-93. PubMed ID: 21783364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
    Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C
    Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazole-aminopiperidine hybrid analogues: design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors.
    Jeankumar VU; Renuka J; Santosh P; Soni V; Sridevi JP; Suryadevara P; Yogeeswari P; Sriram D
    Eur J Med Chem; 2013; 70():143-53. PubMed ID: 24148991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, antimycobacterial and antitumor activities of new (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)methyl N,N-disubstituted dithiocarbamate/O-alkyldithiocarbonate derivatives.
    Güzel O; Salman A
    Bioorg Med Chem; 2006 Dec; 14(23):7804-15. PubMed ID: 16931027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A regio- and stereoselective 1,3-dipolar cycloaddition for the synthesis of new-fangled dispiropyrrolothiazoles as antimycobacterial agents.
    Almansour AI; Ali S; Ali MA; Ismail R; Choon TS; Sellappan V; Elumalai KK; Pandian S
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7418-21. PubMed ID: 23122863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New antitumor imidazo[2,1-b]thiazole guanylhydrazones and analogues.
    Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Calonghi N; Cappadone C; Farruggia G; Zini M; Stefanelli C; Masotti L; Radin NS; Shoemaker RH
    J Med Chem; 2008 Feb; 51(4):809-16. PubMed ID: 18251494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antimicrobial activity of some novel hydrazide, benzochromenone, dihydropyridine, pyrrole, thiazole and thiophene derivatives.
    Refat HM; Fadda AA
    Eur J Med Chem; 2013; 70():419-26. PubMed ID: 24184775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (E)-2-(2-Allylidenehydrazinyl)thiazole derivatives: Design, green synthesis, in silico and in vitro antimycobacterial and radical scavenging studies.
    Hublikar M; Kadu V; Dublad JK; Raut D; Shirame S; Makam P; Bhosale R
    Arch Pharm (Weinheim); 2020 Jul; 353(7):e2000003. PubMed ID: 32372473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2.
    Lu X; Liu X; Wan B; Franzblau SG; Chen L; Zhou C; You Q
    Eur J Med Chem; 2012 Mar; 49():164-71. PubMed ID: 22264895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural product-based design, synthesis and biological evaluation of anthra[2,1-d]thiazole-6,11-dione derivatives from rhein as novel antitumour agents.
    Liang YK; Yue ZZ; Li JX; Tan C; Miao ZH; Tan WF; Yang CH
    Eur J Med Chem; 2014 Sep; 84():505-15. PubMed ID: 25050882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antituberculosis activity of new thiazolylhydrazone derivatives.
    Turan-Zitouni G; Ozdemir A; Kaplancikli ZA; Benkli K; Chevallet P; Akalin G
    Eur J Med Chem; 2008 May; 43(5):981-5. PubMed ID: 17719146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
    Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors.
    Zeytün E; Altıntop MD; Sever B; Özdemir A; Ellakwa DE; Ocak Z; Ciftci HI; Otsuka M; Fujita M; Radwan MO
    Anticancer Agents Med Chem; 2021; 21(9):1099-1109. PubMed ID: 32838725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-Pot Synthesis of Novel Thiazoles as Potential Anti-Cancer Agents.
    Sayed AR; Gomha SM; Taher EA; Muhammad ZA; El-Seedi HR; Gaber HM; Ahmed MM
    Drug Des Devel Ther; 2020; 14():1363-1375. PubMed ID: 32308369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.